Legal Opinion
Federal Trade Commission v. Boehringer Ingelheim Pharmaceuticals, Inc.
Court of Appeals for the D.C. Circuit
Decided February 20, 2015No. 12-5393PublishedCited by 83 opinions
1Opinion of the Court
Opinion for the Court filed by Circuit Judge WILKINS.
WILKINS, Circuit Judge:
In 2009, the Federal Trade Commission initiated an antitrust investigation into a patent settlement agreement between Boehringer Ingelheim Pharmaceuticals, Inc. (“Boehringer”), a brand-name pharmaceutical company, and Barr Industries (“Barr”), a generic drug manufacturer. As part of its investigation, the FTC issued an administrative subpoena seeking various documents relating to the settlement. When Boehringer failed to comply, the FTC initiated an enforcement proceeding in the District Court for the District of…
2Cases cited36 opinions
- Pierce v. UnderwoodSupreme Court of the United States · 1988
- Hickman v. TaylorSupreme Court of the United States · 1947
- United States v. NoblesSupreme Court of the United States · 1975
- United States v. VonnSupreme Court of the United States · 2002
- Senate of the Commonwealth of Puerto Rico on Behalf of Judiciary Committee v. United States Department of JusticeCourt of Appeals for the D.C. Circuit · 1987
31 more not listed; retrieve them via the Exa API.
3Cited by83 opinions
- Shapiro v. United States Department of JusticeDistrict Court, District of Columbia · 2017
- Shapiro v. U.S. Department of JusticeDistrict Court, District of Columbia · 2016
- Hunton & Williams LLP v. U.S. Environmental Protection AgencyDistrict Court, District of Columbia · 2017
- 100reporters LLC v. United States Department of JusticeDistrict Court, District of Columbia · 2017
- Ellis v. United States Department of JusticeDistrict Court, District of Columbia · 2015
78 more not listed; retrieve them via the Exa API.